Dr. Kelsey Klute, MD
Claim this profileUniversity of Nebraska Medical Center
Studies Pancreatic Cancer
Studies Adenocarcinoma
7 reported clinical trials
10 drugs studied
Area of expertise
1Pancreatic Cancer
Stage III
Stage IV
2Adenocarcinoma
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Kelsey Klute, MD is currently running
Botensilimab + Chemotherapy
for Pancreatic Cancer
This trial is testing whether adding a new drug, botensilimab, to standard chemotherapy can better treat patients with advanced pancreatic cancer. The study will ensure the new drug is safe and determine the right dose. It will also compare the effectiveness of the new combination treatment to chemotherapy alone.
Recruiting1 award Phase 2
Ampligen
for Pancreatic Cancer
The purpose of this study is to assess the safety and efficacy of Ampligen in patients with locally advanced pancreatic adenocarcinoma
Recruiting1 award Phase 2
More about Kelsey Klute, MD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Kelsey Klute, MD has experience with
- Gemcitabine
- Nab-paclitaxel
- Nivolumab
- None
- Botensilimab
- Heart Rate Monitoring
Breakdown of trials Kelsey Klute, MD has run
Pancreatic Cancer
Gastroesophageal Adenocarcinoma
Genetic Predisposition
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kelsey Klute, MD specialize in?
Kelsey Klute, MD focuses on Pancreatic Cancer and Adenocarcinoma. In particular, much of their work with Pancreatic Cancer has involved Stage III patients, or patients who are Stage IV.
Is Kelsey Klute, MD currently recruiting for clinical trials?
Yes, Kelsey Klute, MD is currently recruiting for 2 clinical trials in Omaha Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Kelsey Klute, MD has studied deeply?
Yes, Kelsey Klute, MD has studied treatments such as Gemcitabine, Nab-paclitaxel, Nivolumab.
What is the best way to schedule an appointment with Kelsey Klute, MD?
Apply for one of the trials that Kelsey Klute, MD is conducting.
What is the office address of Kelsey Klute, MD?
The office of Kelsey Klute, MD is located at: University of Nebraska Medical Center, Omaha, Nebraska 68198 United States. This is the address for their practice at the University of Nebraska Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.